• Freier Vortrag

SPP1hi Macrophages Interact with CXCR4hi CD62Llo Aged Neutrophils via SPP1-CD44 Axis to Shape the Immunosuppressive Phenotype of the Tumor Microenvironment in HNSCC

Termin

Datum:
Zeit:
Redezeit:
Diskussionszeit:
Ort / Stream:
Spektrum

Themen

  • Kopf-Hals-Onkologie
    • Neue Therapieverfahren

Sprache

  • Englisch

Abstract

Introduction

The immunosuppressive phenotype of the tumor microenvironment (TME) in head and neck squamous cell carcinoma (HNSCC) significantly undermines the efficacy of immune checkpoint inhibitors, such as anti-PD1/L1 therapy. Notably, there is substantial evidence highlighting the contribution of myeloid cells, particularly tumorassociated macrophages (TAMs) and tumor-associated neutrophils (TANs), to the immunosuppressive landscape of the TME. These cells facilitate immune evasion and tumor progression by modulating anti-tumor immune responses and promoting an immune-suppressive niche.

Methods

Flow cytometry was used to detect CXCR4hi CD62Llo aged TAN, SPP1hi TAMs, and T cell exhaustion markers (PD-1, TIM-3, LAG-3) in HNSCC tumor samples (laryngeal and hypopharyngeal cancer).scRNA-seq was performed on tumor tissues from laryngeal and hypopharyngeal cancers.Multiplex immunofluorescence staining was performed for CD44 on CD66b+ TANs and SPP1 on CD68+ TAMs

Results

Flow cytometry revealed upregulated PD-L1 expression on CXCR4hi CD62Llo aged TANs and SPP1hi TAMs, which correlated with the degree of T cell exhaustion.scRNA-seq revealed that CXCR4hi CD62Llo aged TANs and SPP1hi TAMs exhibit significant immunosuppressive phenotypes. Cell-cell communication analysis indicates their interaction through the CD44-SPP1 axis.Multiplex immunofluorescence confirmed the spatial colocalization of CD44 on CD66b+ TANs and SPP1 on CD68+ TAMs, both of which were associated with poor patient prognosis.

Conclusion

In our investigation, we identified CXCR4hi CD62Llo aged TAN with a prolonged-survival phenotype interacting with SPP1hi TAMs via the CD44-SPP1 axis, collaboratively shaping the immunosuppressive TME in HNSCC.

Nein